Revised version of our review article on mRNA splicing in F1000Research has been highlighted in the Faculty of 1000 blog:
The blog entry includes links to our YouTube video:
Short version (3:42)
Long version (9:41)
MutationForecaster® (mutationforecaster.com) is Cytognomix’s patented web-portal for analysis of all types of mutations (coding and non-coding), including interpretation, comparison and management of genetic variant data. It’s now accessible via Illumina’s BaseSpace ecosystem!
MutationForecaster® combines our world-leading genome interpretation software with the Cytognomix User Variation Database and EBI’s Variant Effect Predictor. With our integrated suite of software products, analyze coding, non-coding, and copy number variants, and compare new results with existing or your own database. Select predicted mutations by phenotype using PubMed-indexed articles with Cyto Visualization Analytics. With Workflows, automatically perform end-to-end analysis with all of our software products on your exome, gene panel, or complete genome dataset. It’s an end-to-end genome interpretation solution for research, translational and clinical labs.
You can now experience our integrated suite of genome interpretation products through a free trial of MutationForecaster®. Once you register, analyze datasets that we have analyzed in our peer-reviewed publications with any of our software tools.
- April 18, 2017. US Patent 9,624,549 issued about chemotherapy target identification
- April 8, 2017. Presentation about chemotherapy outcome prediction
- March 31, 2017. New preprint on increased accuracy in radiation biodosimetry
- February 27, 2017. CytoGnomix finalizes contract with Government of Canada